blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2307550

EP2307550 - TRANSFER VEHICLE FOR PRODUCING PROTEINS IN TRANSGENIC ANIMALS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.04.2014
Database last updated on 10.07.2024
Most recent event   Tooltip04.04.2014Application deemed to be withdrawnpublished on 07.05.2014  [2014/19]
Applicant(s)For all designated states
University Court Of The University Of Aberdeen
University Office Regent Walk
Aberdeen AB24 3FX / GB
[2011/15]
Inventor(s)01 / KOLB, Andreas
University of Aberdeen Rowett Institute of Nutrition and Health Greenburn Road
Aberdeen Aberdeenshire AB21 9SB / GB
 [2011/15]
Representative(s)Thom, Russell
Murgitroyd & Company
Scotland House
165-169 Scotland Street
Glasgow G5 8PL / GB
[N/P]
Former [2013/42]Thom, Russell
Murgitroyd & Company
Scotland House
165-169 Scotland Street
Glasgow G5 8PL / GB
Former [2011/15]Ouzman, Beverley Nicola Claire
Murgitroyd & Company 165-169 Scotland Street
Glasgow G5 8PL / GB
Application number, filing date09762026.415.06.2009
[2011/15]
WO2009GB50677
Priority number, dateGB2008001092414.06.2008         Original published format: GB 0810924
[2011/15]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009150477
Date:17.12.2009
Language:EN
[2009/51]
Type: A2 Application without search report 
No.:EP2307550
Date:13.04.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 17.12.2009 takes the place of the publication of the European patent application.
[2011/15]
Search report(s)International search report - published on:EP11.02.2010
ClassificationIPC:C12N15/85, C12N15/90
[2011/15]
CPC:
C12N15/8509 (EP); C12N15/902 (EP); C12N5/16 (EP);
A61K48/00 (EP); C12N2799/021 (EP); C12N2800/30 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/15]
TitleGerman:TRANSFERVEHIKEL ZUR PRODUKTION VON PROTEINEN IN TRANSGENEN TIEREN[2011/15]
English:TRANSFER VEHICLE FOR PRODUCING PROTEINS IN TRANSGENIC ANIMALS[2011/15]
French:VÉHICULE DE TRANSFERT DE GÈNES ET SON UTILISATION[2011/15]
Entry into regional phase13.01.2011National basic fee paid 
13.01.2011Designation fee(s) paid 
13.01.2011Examination fee paid 
Examination procedure13.01.2011Examination requested  [2011/15]
16.03.2011Amendment by applicant (claims and/or description)
01.06.2011Despatch of a communication from the examining division (Time limit: M04)
06.10.2011Reply to a communication from the examining division
17.05.2013Despatch of a communication from the examining division (Time limit: M06)
28.11.2013Application deemed to be withdrawn, date of legal effect  [2014/19]
03.01.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/19]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  01.06.2011
Fees paidRenewal fee
29.06.2011Renewal fee patent year 03
05.11.2012Renewal fee patent year 04
28.06.2013Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.06.201204   M06   Fee paid on   05.11.2012
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO2004029284  (PROTEIN DESIGN LABS INC [US]; DUBRIDGE ROBERT B [US]) [Y] 1-7 * the whole document *;
 [XI]  - KOLB ANDREAS F, "Genome engineering using site-specific recombinases.", CLONING AND STEM CELLS 2002, (2002), vol. 4, no. 1, ISSN 1536-2302, pages 65 - 80, XP007910661 [X] 1-2,4-6 * in particular see Fig. 5B, Table 1 and page 73-77 * [I] 3,7-47
 [XI]  - SORRELL ET AL, "Targeted modification of mammalian genomes", BIOTECHNOLOGY ADVANCES, ELSEVIER PUBLISHING, BARKING, GB, (20051101), vol. 23, no. 7-8, ISSN 0734-9750, pages 431 - 469, XP005076498 [X] 1-2,4-6 * the whole document * [I] 3,7-47

DOI:   http://dx.doi.org/10.1016/j.biotechadv.2005.03.003
 [Y]  - IMPERIALE M J ET AL, "ADENOVIRUS VECTORS: BIOLOGY, DESIGN, AND PRODUCTION", CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, SPRINGER, BERLIN, DE, (20040101), vol. 273, ISSN 0070-217X, pages 335 - 357, XP009070614 [Y] 1-47 * the whole document *
 [Y]  - HOUDEBINE LOUIS-MARIE, "The methods to generate transgenic animals and to control transgene expression.", JOURNAL OF BIOTECHNOLOGY 25 SEP 2002, (20020925), vol. 98, no. 2-3, ISSN 0168-1656, pages 145 - 160, XP002962237 [Y] 1-47 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0168-1656(02)00129-3
 [Y]  - ELIZABETH A MAGA, "The Use of Recombinase Proteins to Generate Transgenic Large Animals", CLONING AND STEM CELLS, MARY ANN LIEBERT, LARCHMONT, US, (20010101), vol. 3, no. 4, ISSN 1536-2302, pages 233 - 241, XP007910656 [Y] 1-47 * the whole document *
 [Y]  - RYDING A D S ET AL, "Conditional transgenic technologies", JOURNAL OF ENDOCRINOLOGY, BRISTOL, GB, (20011001), vol. 171, no. 1, ISSN 0022-0795, pages 1 - 14, XP002249421 [Y] 1-7 * the whole document *

DOI:   http://dx.doi.org/10.1677/joe.0.1710001
Examination   - SHMERLING DORON ET AL, "Strong and ubiquitous expression of transgenes targeted into the beta-actin locus by cre/lox cassette replacement", GENESIS: THE JOURNAL OF GENETICS AND DEVELOPMENT, WILEY-LISS, NEW YORK, NY, US, (20050801), vol. 42, no. 4, doi:10.1002/GENE.20135, ISSN 1526-954X, pages 229 - 235, XP002496257

DOI:   http://dx.doi.org/10.1002/gene.20135
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.